Journal Article

Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation

Toricelli, Mariana, Peres, Giovani B, Silva, Débora CP, Melo, Fabiana HM, Jasiulionis, Miriam G

2013

Overview

Background Anoikis resistance is one of the abilities acquired along tumor progression. This characteristic is associated with metastasis development, since tumorigenic cells must survive independently of cell-matrix interactions in this process. In our laboratory, it was developed a murine melanocyte malignant transformation model associated with a sustained stressful condition. After subjecting melan-a melanocytes to 1, 2, 3 and 4 cycles of anchorage impediment, anoikis resistant cells were established and named 1C, 2C, 3C and 4C, respectively. These cells showed altered morphology and PMA independent cell growth, but were not tumorigenic, corresponding to pre-malignant cells. After limiting dilution of 4C pre-malignant cells, melanoma cell lines with different characteristics were obtained. Previous data from our group showed that increased Timp1 expression correlated with anoikis -resistant phenotype. Timp1 was shown to confer anchorage-independent growth capability to melan-a melanocytes and render melanoma cells more aggressive when injected into mice. However, the mechanisms involved in anoikis regulation by Timp1 in tumorigenic cells are not clear yet. Methods The β1-integrin and Timp1 expression were evaluated by Western blotting and CD63 protein expression by flow cytometry using specific antibodies. To analyze the interaction among Timp1, CD63 and β1-integrin, immunoprecipitation assays were performed, anoikis resistance capability was evaluated in the presence or not of the PI3-K inhibitors, Wortmannin and LY294002. Relative expression of TIMP1 and CD63 in human metastatic melanoma cells was analyzed by real time PCR. Results Differential association among Timp1, CD63 and β1-integrins was observed in melan-a melanocytes, 4C pre-malignant melanocytes and 4C11- and 4C11+ melanoma cells. Timp1 present in conditioned medium of melanoma cells rendered melan-a melanocytes anoikis -resistant through PI3-K signaling pathway independently of Akt activation. In human melanoma cell lines, in which TIMP1 and beta-1 integrin were also found to be interacting, TIMP1 and CD63 levels together was shown to correlate significantly with colony formation capacity. Conclusions Our results show that Timp1 is assembled in a supramolecular complex containing CD63 and β1-integrins along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway, independently of Akt phosphorylation. In addition, our data point TIMP1 , mainly together with CD63 , as a potential biomarker of melanoma.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V
• Subject: Acquisitions & mergers / Analysis / Anoikis - drug effects / Anoikis - genetics / Apoptosis / Biomarkers / Biomedical and Life Sciences / Biomedicine / Cancer Research / Cell adhesion & migration / Cell culture / Cell growth / Cell Line / Cell Survival - drug effects / Cell Survival - genetics / Cell Transformation, Neoplastic - genetics / Cell Transformation, Neoplastic - metabolism / Culture Media, Conditioned - chemistry / Culture Media, Conditioned - pharmacology / Development and progression / Disease Progression / Gene Expression / Genotype & phenotype / Homeostasis / Humans / Integrin beta1 - metabolism / Integrins / Kinases / MART-1 Antigen - metabolism / Melanocytes - drug effects / Melanocytes - metabolism / Melanocytes - pathology / Melanoma / Melanoma - genetics / Melanoma - metabolism / Melanoma - pathology / Metastasis / Models, Biological / Multiprotein Complexes - metabolism / Neoplasm Metastasis / Oncology / Phenotype / Phosphatidylinositol 3-Kinases - antagonists & inhibitors / Phosphatidylinositol 3-Kinases - metabolism / Phosphorylation / Protein Binding / Proteins / Proto-Oncogene Proteins c-akt - metabolism / Signal Transduction / Skin cancer / Tetraspanin 30 - metabolism / Tissue Inhibitor of Metalloproteinase-1 - genetics / Tissue Inhibitor of Metalloproteinase-1 - metabolism / Tissue Inhibitor of Metalloproteinase-1 - pharmacology